06/02/2026
Friday, 6 February 2026
UPDATE
🩸Dr. Wessel Neuhoff
🩸Multiple Myeloma Cancer/Bonemarrow Cancer
🩸🎗🩸
Multiple Myeloma Cancer is an incurable but treatable blood cancer of plasma cells in the bone marrow.
🩸Thursday, 5 February 2026
🩸Day 233 post Stem Cell Transplant
With grateful hearts, we share this update.
We express our sincere gratitude for grace upon grace, mercy upon mercy and blessing upon blessing, generously received from our Almighty God.
We are deeply thankful for the continued prayers, as well as the love and care shown by family, friends, acquaintances, patients, and by healthcare practitioners, cancer researchers, and oncologists.
We extend our heartfelt appreciation to Lancet Laboratories for their exceptional pathology services and specialised diagnostic testing and monitoring of all Wessel’s blood work. We remain eternally grateful.
We continue to believe, trust, and pray that a cure for Multiple Myeloma will be found in the near future.
Wessel is responding well to the maintenance treatment plan.
Dr. Lucille Singh, Haematologist/Oncologist is satisfied with his progress and with the fact that the remaining deficiencies are manageable.
Additional stem cells remain in storage (stored in liquid nitrogen vapour) and is available should Wessel require further support.
Anaemia may take up to two years to recover, where recovery is possible, and this varies from patient to patient.
Wessel is ready to receive his second vaccination following the stem cell transplant.
Due to loss of immunity and immune memory, the conditioning regimen (chemotherapy and/or radiation) eliminates not only diseased cells, but also the immune memory the patient has developed over a lifetime.
Dr. Wessel will resume consultations next week at Neumed, from 9 February 2026, with limited hours and minimal exposure.
Deeply grateful we remain.
